At Beijing Scis, our teams of accomplished scientists are recognized experts in drug discovery and development. Our broad investment in people with a deep understanding of drug development, coupled with state-of-the-art facilities and equipment, allowsBeijing Scis to provide end-to-end
API services from process R&D, to
API manufacturing at phase I, II, III and commercial scale.
Beijing Scis development services also include pre-formulation studies, analytical development, stability evaluation and formulation development, all the way to CMC services.
All of these services are integrated to help our clients quickly and seamlessly move NCEs from preclinical stage to patients.
Our development services include: